Whitehawk Therapeutics, Inc. (WHWK)

Whitehawk Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-63.69	-65.77	-60.51	-110.09	-3.48
Depreciation & Amortization	0.19	0.17	0.16	0.11	0.01
Asset Writedown & Restructuring Costs	-	-	3.72	74.16	-
Loss (Gain) From Sale of Investments	-1.3	-3.14	-1.22	-	-
Stock-Based Compensation	10.84	11.95	9.64	2.11	0.14
Other Operating Activities	0.46	0.52	0.38	-0.95	1.14
Change in Accounts Receivable	-0.42	-3.63	-1.86	14.15	-13.86
Change in Inventory	1.12	-3.27	-1.86	-	-
Change in Accounts Payable	-9.77	-0.13	3.22	8.29	1.08
Change in Other Net Operating Assets	3.02	3.62	-1.32	-10.19	2.28
Operating Cash Flow	-59.55	-59.66	-49.64	-22.42	-12.7
Capital Expenditures	-1.65	-3.97	-0.44	-0.05	-
Cash Acquisitions	-	-	-	25.2	-
Investment in Securities	26.86	87.18	-132.44	-	-
Investing Cash Flow	25.2	83.21	-132.89	25.15	-
Long-Term Debt Issued	-	-	-	-	1.19
Net Debt Issued (Repaid)	-	-	-	-	1.19
Issuance of Common Stock	0.15	0.49	73.28	155.83	-
Preferred Dividends Paid	-	-	-	-4.41	-
Dividends Paid	-	-	-	-4.41	-
Other Financing Activities	-0.02	-0.16	-0.66	-9.62	-
Financing Cash Flow	0.13	0.33	72.62	141.8	1.19
Net Cash Flow	-34.22	23.87	-109.91	144.53	-11.51
Free Cash Flow	-61.2	-63.64	-50.08	-22.47	-12.7
Free Cash Flow Margin	-235.55%	-261.29%	-329.15%	-2006.16%	-87.11%
Free Cash Flow Per Share	-2.26	-2.36	-2.23	-2.52	-5.00
Cash Interest Paid	0.21	0.23	0.23	-	-
Levered Free Cash Flow	-38.69	-37.7	-29.52	-15.23	-12.2
Unlevered Free Cash Flow	-38.6	-37.56	-29.38	-14.81	-11.69
Change in Net Working Capital	7.46	0.75	1.89	-6.19	10.25

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.